Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
meloxicam
CP-Pharma Handelsgesellschaft mbH
QM01AC06
5 Mg/Ml
Solution for Injection
Bovine Canine Feline Porcine
N.S.A.I.D
Authorised
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Melosolute 5 mg/ml solution for injection for cattle, pigs, dogs and cats. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE SUBSTANCE: Meloxicam 5 mg EXCIPIENT: Ethanol 150 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, slightly yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (calves and young cattle), pigs, dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE: For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. PIGS: For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation. For the relief of post operative pain associated with minor soft tissue surgery such as castration. DOGS: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery. CATS: Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 20/02/2014_ _CRN 7016887_ _page number: 1_ 4.3 CONTRAINDICATIONS CATTLE AND PIGS Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal lesions. Do not use in case of hypersensitivity to the active substance or to any of the excipients. For the tre Lue koko asiakirja